Order Article Reprints

Ballester P, Espadas C, Almenara S, Barrachina J, Muriel J, Ramos E, Toral N, Belda C, Peiró AM. CYP2D6 Genotype and Pharmacovigilance Impact on Autism Spectrum Disorder: A Naturalistic Study with Extreme Phenotype Analysis. Pharmaceuticals. 2023; 16(7):954. https://doi.org/10.3390/ph16070954

Ballester, Pura, Cristina Espadas, Susana Almenara, Jordi Barrachina, Javier Muriel, Enrique Ramos, Natalia Toral, César Belda, and Ana M. Peiró. 2023. "CYP2D6 Genotype and Pharmacovigilance Impact on Autism Spectrum Disorder: A Naturalistic Study with Extreme Phenotype Analysis" Pharmaceuticals 16, no. 7: 954. https://doi.org/10.3390/ph16070954

Ballester, P., Espadas, C., Almenara, S., Barrachina, J., Muriel, J., Ramos, E., Toral, N., Belda, C., & Peiró, A. M. (2023). CYP2D6 Genotype and Pharmacovigilance Impact on Autism Spectrum Disorder: A Naturalistic Study with Extreme Phenotype Analysis. Pharmaceuticals, 16(7), 954. https://doi.org/10.3390/ph16070954